arotinolol has been researched along with Cardiomyopathy, Dilated in 1 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, CM | 1 |
Yang, H | 1 |
Li, YS | 1 |
Xu, L | 1 |
Dou, KF | 1 |
Zhao, JL | 1 |
Yuan, XQ | 1 |
Zhao, YF | 1 |
Shi, RF | 1 |
Du, XQ | 1 |
Lu, NQ | 1 |
1 other study available for arotinolol and Cardiomyopathy, Dilated
Article | Year |
---|---|
Effect of arotinolol on left ventricular function in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dilated; Echocardiography; Female; Humans; Male; | 2007 |